衞生署日間醫療中心牌照
EC Specialists Premium (PHF No.: DP000104) L12, Office Tower, Langham Place, 8 Argyle Street, Mong Kok

衞生署日間醫療中心牌照
醫思專匯(PHF No. DP000104): 旺角亞皆老街8號朗豪坊辦公大樓12樓

FibroScan®
FibroScan®

Contact Us

*請選擇診所
*Items
We will contact you to confirm the details of the appointment.
*Required

FibroScan®

FibroScan is the world’s first non-invasive device capable of instant quantification of liver fibrosis. It uses a patented technology known as Vibration-Controlled Transient Elastography (VCTE) to provide reliable, accurate and reproducible assessment of liver tissue stiffness.

What is FibroScan®?

FibroScan® is a non-invasive, convenient and highly accurate test for liver fat content and fibrosis. It utilises the patented Vibration-Controlled Transient Elastography to measure the stiffness, scarring and fat accumulation in the liver. The controlled attenuation parameter (CAP) score and liver stiffness result (measured in eKpa) can measure the fatty change in the liver to diagnose fatty liver disease. It is a non-invasive and painless test. Repeated tests with FibroScan® will not result in any side effects.

The examinee lies on his/ her back. The physician places the FibroScan® probe in an intercostal space with slight pressure. It generates a harmless elastic shear wave from its probe to the liver tissue. This wave is tracked and measured by ultrasound. The examinee could only feel a slight vibration at the tip. FibroScan® examination is radiation-free and non-invasive.

Importance of Liver Fibrosis/ Cirrhosis Assessment

Liver Fibrosis refers to the formation of excess fibrous tissue in the liver as a result of long-term inflammation. When liver fibrosis worsens, it can progress into liver cirrhosis. Many liver cancer is one of the most common causes of cancer death in Hong Kong. Chronic hepatitis B & C, fatty liver disease, diabetes mellitus, and alcoholism are common causes of liver cirrhosis. As liver fibrosis is the early pathological process of liver cirrhosis, assessment of liver fibrosis has become an important clinical parameter to predict the risk of liver-related complications.

Progression of liver cirrhosis
1. Liver inflammation
2. Liver fibrosis
3. Liver cirrhosis

Advantages of Liver Assessment

Blood tests including liver enzymes only reveal the degree of inflammation in various types of hepatitis, but they cannot measure the severity of liver fibrosis. Although liver biopsy is the traditional gold standard to assess liver fibrosis, its use is limited by its invasive nature and the risk of bleeding. Therefore, FibroScan® is the indisputable non-invasive tool for liver fibrosis assessment.

- Non-invasive method
- Allow accurate measurement of liver fibrosis and detection of mild fatty liver
- Results immediately available after the examination
- Numeric results allow monitoring by repeated examinations

Examination Process

1. The examinee lies on his/ her back with right arm raised behind the head.

2. The physician applies water-based gel to the skin and places the FibroScan® probe in an intercostal space with slight pressure.

3. A harmless elastic shear wave is released from the probe to measure the severity of fatty liver and liver fibrosis.

4. The examinee will be informed of the result immediately. In general, the examination lasts around 15 minutes

FibroScan® service is available in the following centre:

Tsim Sha Tsui Branch
Room 209-213, Hong Kong Pacific Centre, 28 Hankow Road, Tsim Sha Tsui (Tsim Sha Tsui station Exit A1)

FibroScan® Q&A

當肝臟內的脂肪佔肝臟總重5%以上,即稱為脂肪肝。以下6類人可能患上脂肪肝:

  • BMI值超過25以上的肥胖者、吃過量甜食及高脂的食物、酗酒者、服藥過量者、丙型肝炎或糖尿病患者、過度節食的減肥者。
  • Chronic hepatitis B and Hepatitis C carrier
  • Persons infected by HIV

  • Persons with high blood pressure or high cholesterol

  • Persons with chronic liver disease

  • Persons with diabetes

  • Persons with high alcohol intake

  • Persons with alcoholic liver disease

  • Do not drink alcoholic beverages 24 hours prior to the test
  • Fasting for 2 hours before the test. Small amount of water is allowed.
  • The FibroScan® test is not recommended for pregnant women.